TRACON Pharmaceuticals, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -3.04%151.000.0%$2687.89m
BNGOBioNano Genomics, Inc. -4.26%10.570.0%$2179.98m
GILDGilead Sciences, Inc. -0.73%65.001.0%$644.16m
AMGNAmgen, Inc. 0.05%251.191.3%$589.76m
REGNRegeneron Pharmaceuticals, Inc. 1.83%525.002.7%$499.40m
ILMNIllumina, Inc. -0.42%430.263.5%$490.22m
ALXNAlexion Pharmaceuticals, Inc. -0.42%155.032.0%$464.00m
CRSPCRISPR Therapeutics AG -0.88%162.500.6%$432.96m
NVAXNovavax, Inc. -3.19%127.0092.9%$401.44m
VRTXVertex Pharmaceuticals, Inc. -0.11%225.001.9%$377.85m
SRPTSarepta Therapeutics, Inc. -2.86%87.9013.8%$331.06m
BIIBBiogen, Inc. -0.13%264.801.7%$313.92m
SRNESorrento Therapeutics, Inc. -6.44%14.251.4%$313.10m
BNTXBioNTech SE -0.29%105.660.0%$292.68m
EXASEXACT Sciences Corp. 0.00%136.8519.6%$253.85m

Company Profile

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.